Turkey: Food and Drugs Law

European and Turkish courts are reshaping how second medical use patent infringement is determined, moving beyond simple SmPC carve-outs to examine real-world prescribing patterns and market behavior. Recent landmark decisions establish that generic pharmaceutical companies may face liability even when patent-protected indications are removed from product documentation, if off-label or cross-label use occurs to a sufficient extent. The evolving legal framework now requires courts to assess both objective ma

NPPs operate as special import regimes that enable access to medicines that are either not authorised in Türkiye or are temporarily unavailable on the domestic market, upon the request of a treating physician.

31.01.2026 tarihli ve 33154 sayılı Resmî Gazete'de Kenevir Yetiştiriciliği ve Kontrolüne Dair Yönetmelik ("Yetiştiricilik Yönetmeliği") ile Kenevirden Elde Edilen Ürünlere Dair Yönetmelik ("Ürün Yönetmeliği") yayımlanarak yürürlüğe girmiştir.